Bright Angel Therapeutics extends seed funding round
Toronto-based Bright Angel Therapeutics, a biotech firm focused on antifungal drugs, has extended its seed funding round.
Toronto-based Bright Angel Therapeutics, a biotech firm focused on antifungal drugs, has extended its seed funding round.
Copyright PEI Media
Not for publication, email or dissemination